Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

Blood (2019) 134 (Supplement_1): 2035.

https://doi.org/10.1182/blood-2019-125232

Published: 2019

Journal Articles

Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2114.

https://doi.org/10.1182/blood-2019-129554

Published: 2019

Journal Articles

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

Tracey Monica Wiggill, MD MBBS, Elizabeth Sarah Mayne, MBBCh, FC Path(SA) Haem, MMed (Haem), Yvonne Perner, MBBCh, FC Path(SA) Anat, MMed (Anat), Jenifer Vaughan, MBBCh, FC Path(SA) Haem, MMed (Haem)

Blood (2019) 134 (Supplement_1): 3418.

https://doi.org/10.1182/blood-2019-126961

Published: 2019

Journal Articles

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Cynthia R. Giver, PhD, Pamela A Shaw, PhD, Helen Fletcher, PhD, Deepak Kaushal, PhD, Garcia Pamela, Deborah Omoyege, Gregory Bisson, MD, Tawanda Gumbo, MD, Robert Wallis, MD, Edmund K. Waller, PhDMD, Daniel Kalman, PhD

Blood (2019) 134 (Supplement_1): 1050.

https://doi.org/10.1182/blood-2019-130275

Published: 2019

Journal Articles

Protocol for an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma (INTEGRATE)

Su-Peng Yeh, MD, Fahad Alsharif, MD DIM, MB ChB, Meral Beksac, MD, Wenming Chen, PhD, Dorotea Fantl, MD, Tatiana Mitina, MD PhD, Estelle Verburgh, MBChB, M MDInt, FCPSA, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kwang-Wei Wu, MD, Zijing Zhang, PhD, Hui Wan, MD PhD, Kihyun Kim, MD

Blood (2019) 134 (Supplement_1): 5577.

https://doi.org/10.1182/blood-2019-122732

Published: 2019

Journal Articles

Seroprevalence of Pre-Existing Nabs Against AAV1, 2, 5, 6 and 8 in South African Hemophilia B Patient Population

Anna Majowicz, PhD, Nolukholo Ncete, MBBCH, Floris van Waes, MSc, Nikki Timmer, BSc, Sander J van Deventer, MD PhD, Johnny N Mahlangu, MBBCH, MMed, FCPath, Valerie Ferreira, PhD

Blood (2019) 134 (Supplement_1): 3353.

https://doi.org/10.1182/blood-2019-128217

Published: 2019

Journal Articles

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Katherine Rae Antel, Estelle Verburgh, MD PhD, Vernon J. Louw, MD PhD, Jenna Oosthuizen, Francois Malherbe, Maartens Gary, Mark Nicol

Blood (2018) 132 (Supplement 1): 5318.

https://doi.org/10.1182/blood-2018-99-112794

Published: 2018

Journal Articles

Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT)

Monzr M. Al Malki, MD, Joo Y. Song, MD, Dongyun Yang, PhD, Thai Cao, MD, Ibrahim Aldoss, MD, Sally Mokhtari, PhD, Sanjeet Dadwal, MD, Ketevan Gendzekhadze, PhD, Anna B Pawlowska, MD, Maryam Ameri, MD, Guido Marcucci, MD, Chatchada Karanes, Pablo Parker, MD, David S. Snyder, MD, David Senitzer, PhD, Auayporn P. Nademanee, MDBS, Stephen J. Forman, MD FACP, Ryotaro Nakamura, MD, Vinod Pullarkat, MD MRCP

Blood (2017) 130 (Supplement 1): 3212.

https://doi.org/10.1182/blood.V130.Suppl_1.3212.3212

Published: 2017

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

BAY 81-8973, a Full-Length Recombinant Factor VIII: Results from Assay Field Study

Monika Maas Enriquez, Horst Beckmann, Yvonne Katterle, Stefan Bruns, Despina Tseneklidou-Stoeter, Steve Kitchen

Blood (2015) 126 (23): 3539.

https://doi.org/10.1182/blood.V126.23.3539.3539

Published: 2015

Journal Articles

Prospective, Multinational/Regional, Non-Interventional Study to Assess Treatment Practices in Anemia Patients Prone to Iron Overload: Results from the 3-Year Transfusional Hemosiderosis Registry (TORS)

Noppadol Siritanaratkul, Jong Wook Lee, Jun Ma, Mustafa Pehlivan, Elena Volodicheva, Qian Jiang, Fatiha Grifi, Bor-Sheng Ko, Raymond Wong, Vernon Louw, Abderrahim Khelif, Ali El-Ali, Jackie Han, Alfonso Losco, Osman Ilhan

Blood (2015) 126 (23): 2152.

https://doi.org/10.1182/blood.V126.23.2152.2152

Published: 2015

Journal Articles

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Timothy P. Hughes, MD, Eduardo Ciliao Munhoz, MD, Alaa Elhaddad, MD PhD, Ong Tee Chuan, MD, Kudrat Abdulkadyrov, MD, Jake Shortt, MD, Hang Quach, MD FRACP, FRCPA, MBBS, Carolina Pavlovsky, MD, Vernon J. Louw, MBChB, M.MD FCP(SA), PhDHPE), Luis Meillon, MD, Lee-Yung Shih, MD Professor, Anna G. Turkina, MD PhD, Jonathan Hwang, PharmD, MBA, Prasanna Kumar Nidamarthy, Darshan Dalal, MD PhD MPH, Jeffrey H. Lipton, PhD MD

Blood (2014) 124 (21): 4542.

https://doi.org/10.1182/blood.V124.21.4542.4542

Published: 2014

Journal Articles

Characteristics of Primary Thrombotic Microangiopathy in Patients with and without Human Immunodeficiency Virus: Thirteen Year Experience at the University of Maryland

Victoria Giffi, MD, Mya S. Thein, MD, Ann Zimrin, MD

Blood (2014) 124 (21): 4203.

https://doi.org/10.1182/blood.V124.21.4203.4203

Published: 2014

Journal Articles

Evaluation Of The AMLprofiler in The South African Context: Report On Preliminary Findings

Marco Alessandrini, PhD, Emil Beltchev, MBChB, Roger Pool, MBChB, Michael Pepper, MBChB, PhD, MD

Blood (2013) 122 (21): 5590.

https://doi.org/10.1182/blood.V122.21.5590.5590

Published: 2013

Journal Articles

ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)

Jeff H. Lipton, PhD, MD, Luis Meillon, MD, Vernon Louw, MD, Carolina Pavlovsky, MD, Lee-Yung Shih, MD, Yu Jin, Sandip Acharya, Richard C. Woodman, Timothy P. Hughes, MD, Anna G. Turkina, MD, PhD

Blood (2013) 122 (21): 4009.

https://doi.org/10.1182/blood.V122.21.4009.4009

Published: 2013

Journal Articles

Immune Tolerance Induction (ITI) in Adults with Congenital Hemophilia: A Multicenter Experience

Rebecca Kruse-Jarres, MD/MPH, Maria Elisa Mancuso, MD, PhD, Eva Mingot Castellano, MD, Johnny Mahlangu, MD

Blood (2012) 120 (21): 1123.

https://doi.org/10.1182/blood.V120.21.1123.1123

Published: 2012

Journal Articles

Plasmablastic Lymphoma – A Single Institution Experience.

Zainab Mohamed, MBChB, FFRad, Nicolas Novitzky, MD, PhD, Andrew McDonald, MBChB, FCP

Blood (2009) 114 (22): 5003.

https://doi.org/10.1182/blood.V114.22.5003.5003

Published: 2009

Journal Articles

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Deferasirox (Exjade®) in Patients with Low/Intermediate-1 Risk MDS and Transfusional Iron Overload.

Emanuele Angelucci, David Bowen, Silvia M.M. Magalhães, Tomasz Lawniczek, Shyanne Douma, Peter Jakobs, Guillermo Garcia-Manero

Blood (2009) 114 (22): 4854.

https://doi.org/10.1182/blood.V114.22.4854.4854

Published: 2009

Journal Articles

Quick, Cheap, and Easy Method for HIV-1 Human Blood Screening.

Tomasz Rozmyslowicz, MD, PhD, Krzysztof Wroblewski, Ph.D., Jaynathan Moodley, M.D., Glen N. Gaulton, Ph.D.

Blood (2007) 110 (11): 2902.

https://doi.org/10.1182/blood.V110.11.2902.2902

Published: 2007

NARROW

One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis

The Changing Face of B-Cell Lymphoma in the Anti-Retroviral Therapy Era in South Africa

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Protocol for an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma (INTEGRATE)

Seroprevalence of Pre-Existing Nabs Against AAV1, 2, 5, 6 and 8 in South African Hemophilia B Patient Population

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT)

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

BAY 81-8973, a Full-Length Recombinant Factor VIII: Results from Assay Field Study

Prospective, Multinational/Regional, Non-Interventional Study to Assess Treatment Practices in Anemia Patients Prone to Iron Overload: Results from the 3-Year Transfusional Hemosiderosis Registry (TORS)

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Characteristics of Primary Thrombotic Microangiopathy in Patients with and without Human Immunodeficiency Virus: Thirteen Year Experience at the University of Maryland

Evaluation Of The AMLprofiler in The South African Context: Report On Preliminary Findings

ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)

Immune Tolerance Induction (ITI) in Adults with Congenital Hemophilia: A Multicenter Experience

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma.

Plasmablastic Lymphoma – A Single Institution Experience.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Deferasirox (Exjade®) in Patients with Low/Intermediate-1 Risk MDS and Transfusional Iron Overload.

Quick, Cheap, and Easy Method for HIV-1 Human Blood Screening.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only